Biotechnology Businesses for Sale and Investment Opportunities

• Healthcare business located in the United Kingdom offering gene therapy products and services. • University spin-out with patented technology and other scientific developments in the pipeline. • Aiming to improve the safety and efficiency of gene therapy. • Top selling products will be tests to ascertain if a person can repair their DNA, testing if a virus used to deliver a gene therapy will actually be safe. • Gene therapy and CAR-T therapy is a rapidly growing field, offering great potential for the company. • Experienced team of scientists and engineers ready to create a successful business. The business is not operational currently. • Unique products and services that can be marketed to potential customers worldwide.

- The business produces 2nm - 8nm of structured nano silicon which helps increase the yield drastically. - Ours is a unique product that works for organic and Inorganic farming. - It is very economical and reduces farmers' input burden. - Our product also reduces the farmer's expenses and gives them a minimum of 20-40% extra yield. - We have a marketing capability to supply the whole of India. - We have received good reviews from farmers and our dealers. - The manufacturing capacity is 10k ltrs/ month. - We have about 200 dealers who supply our products to the farmers. - The cost of 1L of our product is INR 1.7k, and our production cost is INR 460. - The owner has an experience of 6-7 years in the business.

- Business is involved in the sale of tissue-cultured mushroom seeds. - The owner has an experience of 7+ years in this industry. - One pack of tissue-cultured mushroom seeds weighs 200g and is sold for LKR 150. - The demand is very high, we receive around 150 orders every day and our machine has a manufacturing capacity of 100 packs per day. - The packs are directly sold to customers. - The promotor has received the best entrepreneur award in Monaragala, Sri Lanka. - Most of the work of the business is done through the machines and this is the reason for us to have limited employees. And we need these employees to operate the business from manufacturing to packaging.

- Have catered to 60+ clients. We have clients from 6 different countries. - We have tied up with a network of 150 hospitals across 30 cities to conduct the trials. - The clinical trials are conducted in multiple sites. - We have 13 ongoing collaborations with pharmaceutical companies or research institutions. - Average duration of the clinical trials is 5 months. - We abide by the ICH-GCP guidelines to handle the confidentiality and privacy of participants' data during and after the trial. - One project takes 4-5 months and we receive the entire amount post-completion of the project itself.

- We are one of the most progressive genomics precision diagnostic labs with cutting-edge equipment for next-generation sequencing and cellular Therapy in Asia. - We focus on B2B and B2C services. Clients are other laboratories, research institutes, hospitals and sometimes patients. - Started working on a lot more new projects which have increased our sales. Post pandemic, we are able to sign more contracts and projects from clients. - Business has 100 employees and we hire part-time staff and interns as well based on the project. With this process, we are able to generate higher sales with fewer permanent employees. - We generate revenue by charging service fee from clients for our research and development services. We also develop new types of tests, technologies for research purposes and let others use our patents.

- 300 students have registered for the current year. - No. can be increased provided full fledge market franchisees are given. - In the field of biotechnology training we are next to the top-notch leaders. - Promoter has 12-13 years of experience in this industry.

- Founded by a historical Italian research group. - Products are distributed throughout Europe, the MENA area, and Australia. - Distribution in the USA market will start next year. - The company has an internal R&D department. - Business has third-party manufacturing but the products are sold under its own brand name. - Since the company has third-party manufacturing, the business has a high turnover per employee. The company already has an established distributor network, which is the reason for the high demand. - With third-party manufacturing the company is able to meet this demand, with fewer employees. - The company has experienced a high growth rate and is expected to continue with the same. This is because of the established partnership and expansion plans of the company.

- Qualified supplier and service provider for around 300 clients. - We source products from private-label manufacturers in EU, US, and Asia and supply them under our own brand. - We are also an authorized distributor of other medical device brands and have sole distributorship rights in German-speaking countries. - Stabile and longtime customer relationships with both clients and suppliers. - Kind of clients: public and private labs, medical offices, and distributors in the EU. - Revenue split: 70% of our sales are generated from our own brand products and 30% is from the distribution of other brand products. - On the existing customer base and portfolio basis, a lucrative expansion of the business is possible. - We manage to generate current sales since we have a large and loyal client base and we hire freelancers for sales and marketing on an ad-hoc basis.

We have launched 15 innovative products. The products are planned for sales through omni channel marketing. We have presence in general trade and ecomm. We need to enter into exports, modern trade and multiple market places. .

- We are a biopharma company dealing in the research and development of various formulations and clinical trials. - As of now the company has rights of 15 formulations and has a large market share in this industry. - Our company has two revenue models. We treat patients majorly from the countries such as Australia, Canada, and the USA using our technology. - These patients especially travel to India for our treatments. - We don't have our own clinics but subcontract hospitals in Mumbai to use our technology. - Another revenue source is to supply our formulations and technology to various other hospitals & clinics and receive a royalty from them. - We also have discussions going on with various insurance companies to provide coverage for our treatments. - Since the majority of our clients are from the USA we are planning to start a drug manufacturing unit there. - This unit will be under the USFDA regulations which would increase our scope to expand into various other international markets. - The company has two partners with a 70% and 30% stake distribution. - Business has not taken any loans previously. - We are seeking investment to establish the manufacturing unit.

- Bio-diagnostic research company developing a cancer diagnosis, prognosis, and discovery tool. - Promoter has set up a laboratory with his own funds. - The laboratory has the basic equipment necessary to develop the product. - The lab has a collaboration with a French laboratory. - Developing proof of concept as of now. - We require funds to hire technical manpower and conduct trials in hospitals. - The promoter has a doctorate in Neurobiology from France with 15 years of industrial experience in similar areas. They have experience in oncology as well. - Looking for investors to bring the ideas into reality. The investor will receive a 30% stake in the company.